GWAS |
- Amyotrophic lateral sclerosis (age of onset) ( 22959728)
- Body fat distribution (leg fat ratio) ( 30664634)
- Body fat distribution (trunk fat ratio) ( 30664634)
- Body size at age 10 ( 32376654)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (min-P) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Crohn's disease ( 28067908)
- Inflammatory bowel disease ( 28067908)
- Neuritic plaque ( 31497858)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
|
- Atrial fibrillation ( 30061737)
- Bevacizumab-induced composite toxicity (either hypertension or proteinuria) ( 34616010)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Left ventricular mass to end-diastolic volume ratio (MTAG) ( 33495596)
- Mean platelet volume ( 32888494)
- Mean spheric corpuscular volume ( 32888494)
- Nicotine dependence symptom count ( 25555482)
- Reaction time ( 29844566)
- Schizophrenia ( 28991256 30285260)
|